A twice-yearly HIV prevention injection could transform HIV prevention as we know it, but innovation alone doesn't guarantee uptake.

In our new Daily Maverick op-ed, we explore the behavioural and social factors that will shape the success of Lenacapavir, from perceptions of risk and prevention to stigma, misinformation, and health system barriers. 

Give it a read here!